uveal autoantigen with coiled-coil domains and ankyrin repeats
RGD ID:
1560011
Description:
Predicted to enable transcription regulator inhibitor activity. Predicted to be involved in intrinsic apoptotic signaling pathway; negative regulation of inflammatory response; and negative regulation of intracellular signal transduction. Predicted to act upstream of or within several processes, including positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of protein import into nucleus; and response to UV. Predicted to be located in membrane; nucleus; and perinuclear region of cytoplasm. Predicted to be part of apoptosome. Predicted to be active in cytosol and nucleus. Orthologous to human UACA (uveal autoantigen with coiled-coil domains and ankyrin repeats); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil; acetamide.
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UACA mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to UACA promoter]
[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of UACA mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of UACA mRNA
[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of UACA mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of UACA mRNA
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UACA mRNA
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UACA mRNA
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UACA mRNA